Five Ways GLP-1 Drugs Are Reshaping the Supplement Aisle
Nutrient gaps, gut side effects, muscle loss, hair and nail changes and weight regain are driving a new category of GLP-1 companion supplements.
food news. food policy. food tech.
food news. food policy. food tech.
Tag glp-1
Five Ways GLP-1 Drugs Are Reshaping Supplement Demand
GLP-1 drug users are driving supplement demand for nutrient gaps, digestion, muscle, beauty and weight maintenance after stopping treatment.
GLP-1 Users Are Rewriting the Restaurant Order: Smaller Plates, More Protein, Less Beer
A Lumina Intelligence report finds GLP-1 users pick restaurants for health, want smaller high-protein portions, and are swapping beer for wine and lighter cocktails.
PepsiCo Cuts Its Profit Forecast and Promises More Cost Cuts as North American Snacks Stall
PepsiCo now expects 1% to 2% core earnings growth for 2026, down from the low end of 4% to 6%. CEO Ramon Laguarta says more structural cost cuts are coming.
India’s Food Regulator Challenges a GLP-1 Protein Drink From Dr Reddy’s and Nestle Health Science
FSSAI has issued show-cause notices over Celevida GLP+, flagging claims about preserving lean muscle during GLP-1 therapy. Amazon, Flipkart and Netmeds were also served.
GLP-1 Side Effects Are Still Coming Into Focus as Use Spreads to Kids
New research links GLP-1 drugs to hair loss, prescriptions for children aged 8 to 11 have risen 310-fold, and the WHO advises against the drugs for kids under 10.
Study: Diet Support Cut Weight Regain After Stopping GLP-1s
In a 39-person pilot study, people who stopped GLP-1 drugs regained about 3.6% of body weight with meals or an app, versus 10.75% without support.
The Giant Company Launches Grocery Store Tours for GLP-1 Users
The Giant Company is running one-hour tours at six Pennsylvania stores to help GLP-1 users shop for protein-rich, high-fiber foods.
After GLP-1s: Weight Maintenance May Be Food’s Next Frontier
With one-year GLP-1 discontinuation rates of 36% to 65%, analysts see a new market in helping people keep weight off after the drugs.
Fibermaxxing Is Booming. Experts Say Ramp Up Slowly.
Gut health experts back the fibermaxxing trend but warn that jumping from little fiber to a lot can bring bloating and discomfort.
BODi’s CEO Says AI Won’t Complicate Active Nutrition
BODi CEO Carl Daikeler says active nutrition simplicity is the strategy, even as AI, GLP-1 drugs, and longevity trends reshape consumer expectations.
Costco Is Betting Big on Protein. Here’s What That Means.
Costco's Q3 results show Costco protein private label is no accident: GLP-1 drug adoption is actively reshaping club retail's product strategy.